Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 4 (8th April 2022) - Kutsch, Nadine; Pallasch, Christian; Tausch, Eugen; Böhme, Volkmar; Ritgen, Matthias; Liersch, Rüdiger; Wacker, Alexander; Jacobs, Georg; Trappe, Ralf Ulrich; Dreger, Peter; Fischer, Kirsten; Fink, Anna-Maria; et al.